Targeted Therapy

Healio spoke with Jonathan M. Gerber, MD, of the Center for Cancer Excellence at the University of Massachusetts Medical School and UMass Memorial Health Care System, and HemOnc Today Editorial Board member, about the clinical implications of the BEAT-AML trial and genetic testing in AML.

Healio spoke with Debu Tripathy, MD, about the use of targeted therapies in breast cancer.

Healio spoke with Debu Tripathy, MD, about treatments being developed for breast cancer.

In this video, Patrick Borgen, MD, chair of the department of surgery at Maimonides Medical Center, discussed the virtual platform and central learning opportunities from the 38th Annual Miami Breast Cancer Conference.

In this video, Kelly K. Hunt, MD, FACS, FSSO, professor and chair of the department of breast surgical oncology at University of Texas MD Anderson Cancer Center, highlighted topics in targeted therapies at the virtual 38th Miami Breast Cancer Conference.

Neetu Gupta, PhD, associate professor at Cleveland Clinic Foundation, discussed exciting CAR-T presentations featured at the ASH Annual Meeting and Exposition, including new targets for lymphoid malignancies and CAR modifications to improve safety.

In this video, Roy S. Herbst, MD, PhD, associate cancer center director for translational research at Yale Cancer Center, provided a quick rundown of presentations from the Chemotherapy Foundation Symposium that focused on targeted therapy.

A “sandwich” approach to melanoma treatment consisting of immunotherapy between two targeted therapy courses showed a trend toward improved total PFS, according to study results presented at ESMO Virtual Congress 2020.